FAM
CELL

Fred Alger Management’s PhenomeX Inc. Common Stock CELL Stock Holding History

Fred Alger Management’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-84,085
Closed -$1.53M – 565
2021
Q4 		$1.53M Buy
+84,085
New +$1.81M ﹤0.01% 373
2021
Q3 		– Sell
-3,057,808
Closed -$137M – 580
2021
Q2 		$137M Buy
3,057,808
+199,911
+7% +$9.27M 0.32% 105
2021
Q1 		$144M Buy
2,857,897
+2,088,128
+271% +$142M 0.38% 90
2020
Q4 		$68.8M Buy
769,769
+762,337
+10,257% +$64.1M 0.18% 135
2020
Q3 		$568K Buy
+7,432
New +$472K ﹤0.01% 368

Other funds holding CELL

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $95.1B AUM 30.55% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.69B AUM 20.52% 1-Year Est. Return
SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return